SAFETY
SAFETY is a behavioral intervention with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
Theater in School Sex Education - a Randomized Controlled Study
Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy
Clinical Trials (5)
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
Theater in School Sex Education - a Randomized Controlled Study
Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy
All 5 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 5